Income Statement Balance Sheet Cash Flow Business Segments

Foghorn Therapeutics Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Market Cap$264.2M

No metrics found for this filter.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.